Albania vs Tunisia: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Albania
0.1%
in 2024
Tunisia
0.1%
in 2024
Albania rank
134th
Tunisia rank
134th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Albania
- Tunisia
How they compare
Albania currently reports 0.1% against 0.1% in Tunisia, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Tunisia ahead.
Albania ranks 134th and Tunisia ranks 134th of 246 countries.
Albania has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Albania | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.2% | 0.1% | 0.1% | Albania |
| 2020s | 0.2% | 0.1% | 0.1% | Albania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Albania or Tunisia?
- Albania, at 0.1% against 0.1% in Tunisia as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Albania and Tunisia?
- 0.0%, with Albania ahead.
- How many years of comparable data are there for Albania and Tunisia?
- 10 years are reported by both, from 2015 to 2024.
- How do Albania and Tunisia rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Albania ranks 134th and Tunisia ranks 134th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.